29543778|t|Antioxidant and Neuroprotective Effects of N-((3,4-Dihydro-2H-benzo[h]chromen-2-yl)methyl)-4-methoxyaniline in Primary Cultured Rat Cortical Cells: Involvement of ERK-CREB Signaling.
29543778|a|Excitotoxicity and oxidative stress play vital roles in the development of neurodegenerative disorders including Alzheimer's disease (AD). In the present study, we investigated the effect of N-((3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl)-4-methoxyaniline (BL-M) on excitotoxic neuronal cell damage in primary cultured rat cortical cells, and compared to that of memantine, a non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist clinically used to treat AD. We found that BL-M inhibited glutamate- or N-methyl-d-aspartate (NMDA)-induced excitotoxic cell damage. The IC50 value of BL-M against NMDA toxicity was comparable to that of memantine. BL-M potently inhibited intracellular reactive oxygen species generated by glutamate or NMDA. Additionally, it inhibited the formation of 1,1-diphenyl-2-picryl-hydrazyl radicals in vitro and lipid peroxidation in rat brain homogenates. In contrast, memantine showed minimal or negligible antioxidant activity. Western blotting and immunocytochemical analyses showed that BL-M, not memantine, increased the ERK1/2 phosphorylation and subsequent phosphorylation of cAMP response element-binding protein (CREB). The inhibition of NMDA toxicity by BL-M was dramatically reversed by U0126, a well-known MEK inhibitor, suggesting that ERK1/2-mediated CREB phosphorylation is required for the neuroprotective action. Collectively, in this study, we demonstrated the neuroprotective effect of a newly synthesized chromene derivative BL-M and its underlying action mechanism(s). In contrast to memantine, BL-M exhibited marked antioxidant activity. Furthermore, it enhanced the ERK-mediated phosphorylation of CREB, which plays a crucial neuroprotective role. Our findings suggest that BL-M may be beneficial for AD and other neurodegenerative disorders associated with excitotoxicity as well as oxidative stress.
29543778	43	107	N-((3,4-Dihydro-2H-benzo[h]chromen-2-yl)methyl)-4-methoxyaniline	Chemical	-
29543778	128	131	Rat	Species	10116
29543778	163	166	ERK	Gene	24338
29543778	167	171	CREB	Gene	81646
29543778	183	197	Excitotoxicity	Disease	
29543778	258	285	neurodegenerative disorders	Disease	MESH:D019636
29543778	296	315	Alzheimer's disease	Disease	MESH:D000544
29543778	317	319	AD	Disease	MESH:D000544
29543778	374	438	N-((3,4-dihydro-2H-benzo[h]chromen-2-yl)methyl)-4-methoxyaniline	Chemical	-
29543778	440	444	BL-M	Chemical	MESH:D001761
29543778	449	481	excitotoxic neuronal cell damage	Disease	MESH:D009410
29543778	502	505	rat	Species	10116
29543778	546	555	memantine	Chemical	MESH:D008559
29543778	648	650	AD	Disease	MESH:D000544
29543778	666	670	BL-M	Chemical	MESH:D001761
29543778	681	690	glutamate	Chemical	MESH:D018698
29543778	695	715	N-methyl-d-aspartate	Chemical	MESH:D016202
29543778	717	721	NMDA	Chemical	MESH:D016202
29543778	731	754	excitotoxic cell damage	Disease	MESH:D002280
29543778	774	778	BL-M	Chemical	MESH:D001761
29543778	787	791	NMDA	Chemical	MESH:D016202
29543778	792	800	toxicity	Disease	MESH:D064420
29543778	827	836	memantine	Chemical	MESH:D008559
29543778	838	842	BL-M	Chemical	MESH:D001761
29543778	876	899	reactive oxygen species	Chemical	MESH:D017382
29543778	913	922	glutamate	Chemical	MESH:D018698
29543778	926	930	NMDA	Chemical	MESH:D016202
29543778	976	1015	1,1-diphenyl-2-picryl-hydrazyl radicals	Chemical	-
29543778	1029	1034	lipid	Chemical	MESH:D008055
29543778	1051	1054	rat	Species	10116
29543778	1087	1096	memantine	Chemical	MESH:D008559
29543778	1209	1213	BL-M	Chemical	MESH:D001761
29543778	1219	1228	memantine	Chemical	MESH:D008559
29543778	1244	1250	ERK1/2	Gene	50689;116590
29543778	1301	1338	cAMP response element-binding protein	Gene	81646
29543778	1340	1344	CREB	Gene	81646
29543778	1365	1369	NMDA	Chemical	MESH:D016202
29543778	1370	1378	toxicity	Disease	MESH:D064420
29543778	1382	1386	BL-M	Chemical	MESH:D001761
29543778	1416	1421	U0126	Chemical	MESH:C113580
29543778	1467	1473	ERK1/2	Gene	50689;116590
29543778	1483	1487	CREB	Gene	81646
29543778	1643	1651	chromene	Chemical	MESH:D001578
29543778	1663	1667	BL-M	Chemical	MESH:D001761
29543778	1723	1732	memantine	Chemical	MESH:D008559
29543778	1734	1738	BL-M	Chemical	MESH:D001761
29543778	1807	1810	ERK	Gene	24338
29543778	1839	1843	CREB	Gene	81646
29543778	1915	1919	BL-M	Chemical	MESH:D001761
29543778	1942	1944	AD	Disease	MESH:D000544
29543778	1955	1982	neurodegenerative disorders	Disease	MESH:D019636
29543778	1999	2013	excitotoxicity	Disease	
29543778	Negative_Correlation	MESH:D001761	MESH:D002280
29543778	Positive_Correlation	MESH:D018698	MESH:D002280
29543778	Negative_Correlation	MESH:C113580	MESH:D064420
29543778	Positive_Correlation	MESH:D017382	MESH:D018698
29543778	Positive_Correlation	MESH:D016202	MESH:D017382
29543778	Association	24338	81646
29543778	Association	116590	81646
29543778	Negative_Correlation	MESH:C113580	MESH:D001761
29543778	Positive_Correlation	MESH:D001761	50689
29543778	Negative_Correlation	MESH:D001761	MESH:D016202
29543778	Negative_Correlation	MESH:D001761	MESH:D018698
29543778	Negative_Correlation	MESH:D001761	MESH:D064420
29543778	Negative_Correlation	MESH:C113580	MESH:D016202
29543778	Positive_Correlation	MESH:D016202	MESH:D002280
29543778	Positive_Correlation	MESH:D001761	116590
29543778	Negative_Correlation	MESH:D001761	MESH:D017382
29543778	Negative_Correlation	MESH:D008559	MESH:D000544
29543778	Negative_Correlation	MESH:D001761	MESH:D008055
29543778	Association	50689	81646
29543778	Positive_Correlation	MESH:D001761	81646
29543778	Positive_Correlation	MESH:D001761	24338
29543778	Negative_Correlation	MESH:D001761	MESH:D009410
29543778	Comparison	MESH:D001761	MESH:D008559

